QTRXQuanterix Corp

Nasdaq quanterix.com


$ 14.13 $ 0.94 (7.12 %)    

Wednesday, 18-Sep-2024 15:59:49 EDT
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ 14.14
$ 14.11 x 100
$ 14.14 x 100
-- - --
$ 10.50 - $ 29.70
757,571
na
542.68M
$ 1.52
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 02-29-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-06-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 03-01-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 03-05-2021 12-31-2020 10-K
16 11-06-2020 09-30-2020 10-Q
17 08-05-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 03-13-2020 12-31-2019 10-K
20 11-08-2019 09-30-2019 10-Q
21 08-06-2019 06-30-2019 10-Q
22 05-10-2019 03-31-2019 10-Q
23 03-18-2019 12-31-2018 10-K
24 11-07-2018 09-30-2018 10-Q
25 08-10-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 03-19-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 scotiabank-maintains-sector-outperform-on-quanterix-lowers-price-target-to-28

Scotiabank analyst Sung Nam maintains Quanterix (NASDAQ:QTRX) with a Sector Outperform and lowers the price target from $32 ...

 td-cowen-maintains-hold-on-quanterix-lowers-price-target-to-15

TD Cowen analyst Daniel Brennan maintains Quanterix (NASDAQ:QTRX) with a Hold and lowers the price target from $17 to $15.

 quanterix-q2-2024-gaap-eps-025-beats-026-estimate-sales-34381m-beat-33701m-estimate

Quanterix (NASDAQ:QTRX) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.26) by ...

 quanterix-new-data-show-that-applying-a-combination-of-ad-relevant-biomarkers-with-p-tau-217-significantly-reduces-the-intermediate-zone-of-a-two-cutoff-p-tau-217-test-while-preserving-high-accuracy-above-90

Quanterix improves on its best-in-class p-Tau 217 standalone test with new multi-marker approach reducing the number of patient...

 goldman-sachs-maintains-buy-on-quanterix-lowers-price-target-to-24

Goldman Sachs analyst Matthew Sykes maintains Quanterix (NASDAQ:QTRX) with a Buy and lowers the price target from $35 to $24.

 quanterix-q1-2024-gaap-eps-026-beats-033-estimate-sales-32066m-beat-31620m-estimate

Quanterix (NASDAQ:QTRX) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.33) by ...

 canaccord-genuity-maintains-buy-on-quanterix-lowers-price-target-to-25

Canaccord Genuity analyst Kyle Mikson maintains Quanterix (NASDAQ:QTRX) with a Buy and lowers the price target from $32 to $25.

 quanterix-reveals-specific-partnership-path-for-laboratories-interested-in-offering-tau-based-research-and-diagnostic-testing-services

Those interested in building Alzheimer's disease (AD) testing infrastructure should contact Quanterix to discuss potential ...

 scotiabank-maintains-sector-outperform-on-quanterix-raises-price-target-to-32

Scotiabank analyst Sung Nam maintains Quanterix (NASDAQ:QTRX) with a Sector Outperform and raises the price target from $30 ...

 quanterix-granted-breakthrough-device-designation-from-us-fda-for-blood-based-p-tau-217-test-for-alzheimers-disease

Quanterix Corporation (NASDAQ:QTRX), a leading provider of ultra-sensitive research products and high-definition diagnostics, a...

 quanterix-sees-fy24-revenue-139m-144m-vs-1382m-est

2024 Full Year Business OutlookManagement expects full-year 2024 revenue to be in the range of $139 to $144 million. This guide...

 quanterix-q4-eps-033-misses-032-estimate-sales-3155m-beat-2984m-estimate

Quanterix (NASDAQ:QTRX) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.32) b...

 earnings-scheduled-for-february-29-2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

 earnings-preview-quanterix
Earnings Preview: Quanterix
02/28/2024 17:02:16

 earnings-scheduled-for-february-27-2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

 reported-earlier-quanterix-reaffirmed-its-2023-guidance-expects-gaap-gross-margin-in-the-high-50s-percent-and-non-gaap-gross-margin-to-be-around-50-q4-earnings-call-rescheduled

Quanterix Corporation (NASDAQ:QTRX) today announced that it has rescheduled the release of its financial results for the fourth...

 a-preview-of-quanterixs-earnings
A Preview Of Quanterix's Earnings
02/26/2024 20:01:29

 quanterix-announces-first-collaborations-with-five-health-networks-to-aid-the-diagnosis-and-clinical-management-of-individuals-with-alzheimers-disease

AdventHealth, Mass General Brigham, Mayo Clinic, MUSC, and UPMC will leverage Quanterix technology and assays to streamline car...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION